Found: 2
Select item for more details and to access through your institution.
Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies.
- Published in:
- Cephalalgia, 2024, v. 44, n. 2, p. 1, doi. 10.1177/03331024231222923
- By:
- Publication type:
- Article
Patterns of response to anti‐calcitonin gene‐related peptide monoclonal antibodies during first 6 months of treatment in resistant migraine patients: Impact on outcome.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 7, p. 1937, doi. 10.1111/ene.15816
- By:
- Publication type:
- Article